Sunday, March 13, 2016 2:40:28 PM
https://www.pehub.com/2016/02/spectrascience-buys-assets-of-vc-backed-oncoscope/
"SpectraScience buys assets of VC-backed Oncoscope
February 23, 2016 By Stephanie Rogan Follow @stephanierogan
SpectraScience Inc, a medical device company, acquired the assets of Oncoscope Inc, a Durham, North Carolina-based developer of a proprietary optical imaging system. Oncoscope has received funding from Applied Ventures, IDEA Fund Partners and others, according to earlier press releases.
PRESS RELEASE
SAN DIEGO, CA–(Marketwired – February 23, 2016) – SpectraScience, Inc. (OTCQB: SCIE), a medical device company utilizing light technologies to detect and diagnose cancers, announced today that it has acquired the assets of Oncoscope, Inc. of Durham, North Carolina. Oncoscope developed a proprietary optical imaging system to provide immediate, minimally-invasive detection of pre-cancerous epithelial tissues using scattered white light. Their first target indication was for Barrett’s Esophagus, a precursor for cancer of the esophagus.
“The Oncoscope technology is the perfect complement to ours. SpectraScience’s Laser Induced Fluorescence Spectroscopy (LIFS) measures concentration of specific biomarkers in epithelial tissues. The strength of Oncoscope’s technology is its focus on enlarged cell nuclei, an early marker of pre-cancers and cancers. Both technologies arrive at the same conclusion by measuring different indicators. Having two complementary technologies allows us to address multiple types of cancers including both esophageal and colon cancers,” said Michael Oliver, President and Chief Executive Officer of SpectraScience. He went on to say, “Oncoscope’s focus on a diagnostic for Barrett’s Esophagus will shorten the development time for a commercial product to address this indication. With a solution for diagnosis of cancer in the upper GI as well as the lower GI, we will be able to more efficiently utilize our manufacturing capabilities and leverage the sales channel to Gastroenterologists.”...."
Owning shares or partnership units is not an endorsement of management to break the Sabbaths or to do any other unGodliness. I do not share in their sin or guilt and they mislead others on their own accord. I have no major stakes to influence any company.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM